Jane Street Group, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$1.61 - $3.83 $351,946 - $837,238	218,600 Added 635.47%	253,000 $556,000
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $55,384 - $93,912	34,400 New	34,400 $56,000
Q1 2022 May 17, 2022	BUY	$3.34 - $5.56 $118,570 - $197,380	35,500 Added 64.78%	90,300 $419,000
Q4 2021 Feb 15, 2022	BUY	$4.81 - $11.92 $131,313 - $325,416	27,300 Added 99.27%	54,800 $274,000
Q3 2021 Nov 16, 2021	BUY	$11.34 - $21.37 $142,884 - $269,262	12,600 Added 84.56%	27,500 $331,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $79,540 - $117,711	4,100 Added 37.96%	14,900 $315,000
Q1 2021 May 18, 2021	SELL	$25.12 - $36.89 $2.14 Million - $3.14 Million	-85,100 Reduced 88.74%	10,800 $303,000
Q4 2020 Feb 17, 2021	BUY	$24.2 - $35.76 $537,240 - $793,872	22,200 Added 30.12%	95,900 $2.49 Million
Q3 2020 Nov 17, 2020	SELL	$31.18 - $52.71 $1.01 Million - $1.71 Million	-32,400 Reduced 30.54%	73,700 $2.74 Million
Q2 2020 Aug 17, 2020	BUY	$30.04 - $51.31 $2.85 Million - $4.87 Million	94,900 Added 847.32%	106,100 $5.44 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $38,940 - $65,802	1,100 Added 10.89%	11,200 $668,000
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $114,072 - $143,948	2,800 Added 38.36%	10,100 $448,000
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $46,158 - $56,532	700 Added 10.61%	7,300 $528,000
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $289,080 - $348,282	6,600	6,600 $331,000

200

119M

171K

679K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $55.2M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.